(Q43756553)

English

Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.

scientific article published in June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

K Mullane

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C Kalnicky

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Rodriguez

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

J Klein

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

P Stiff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

89-96

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17461992%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro susceptibilities of zygomycetes to conventional and new antifungals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Activity of posaconazole in the treatment of central nervous system fungal infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Activity of posaconazole in treatment of experimental disseminated zygomycosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Refractory coccidioidomycosis treated with posaconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00208.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43756553&oldid=2103072835"